Showing 1371-1380 of 1498 results for "".
- New From Cutera: Juliet and Secret RFhttps://modernaesthetics.com/news/new-from-cutera-juliet-and-secret-rf/2472149/Cutera has introduced two new devices to its laser and energy-based device offerings: Juliet™ and Secret RF
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- New from Silk'n: Meet Titan by Silk'nhttps://modernaesthetics.com/news/new-from-silkn-meet-titan-by-silkn/2472181/Home-use devices represent a hot growth category, and Silk'n is now introducing Titan by Silk'n for at-home skin tightening and lifting. Titan combines infrared energy to increase blood circulation and improve skin tone and texture, LED lig
- FDA Clears Thermage's FLX System for Smoothing Skinhttps://modernaesthetics.com/news/fda-clears-thermages-flxtm-system-for-smoothing-skin/2472182/The U.S. Food and Drug Administration (FDA) granted 510(K) clearance to Solta Medical’s new Thermage FLXTM System for smoothing skin on the face, eyes, and body. The Thermage FLX features a new optimized energy delivery algorithm, known
- FDA Clears Fotona's StarWalker MaQX Ultra Performance Q-Switched Systemhttps://modernaesthetics.com/news/fda-clears-fotonas-starwalker-maqx-ultra-performance-q-switched-system/2472191/The FDA has cleared Fotona's StarWalker MaQX Q-Switched laser system for treating tattoos, pigmented and vascular lesions, acne and scar revision, and permanent hair reduction. The Verde 532 mode in a "tattoo laser" is exclusive to the MaQX. Sales in the US will begin immediately. T
- Sculpture OK'd as Double Chin Treatmenthttps://modernaesthetics.com/news/sculpsure-oked-as-double-chin-treatment/2472190/Cynosure's SculpSure® is now cleared for submental fat reduction. The U.S. Food and Drug Administration (FDA) granted an expanded FDA 510(k) clearance for this area, Hologic, Inc. reports.
- Allergan Upgrades Brilliant Distinctions® Patient Loyalty Programhttps://modernaesthetics.com/news/allergan-upgrades-brilliant-distinctions-patient-loyalty-program/2472200/Allergan is launching the next generation of its U.S.-based Brilliant Distinctions® program. The new offering incorporates digital innovation to enhance the consumer experience and dr
- Bonti's Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://modernaesthetics.com/news/bontis-gateway-neuromodulator-performs-well-in-pase-2a-for-glabellar-lines/2472208/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serot
- Neothetics, Inc.'s Stock Tumbles Following "Unambiguous" Negative LIPO-202 Resultshttps://modernaesthetics.com/news/neothetics-incs-stock-tumbles-following-unambiguous-negative-lipo-202-results/2472217/Neothetics, Inc.’s LIPO-202 for the reduction of submental subcutaneous fat failed to demonstrate improvement on any efficacy measurements or separation from placebo in a Phase 2 proof-of-concept trial. Neothetics Inc. shares d
- Sculpture OK'd for Back, Inner and Outer Thighshttps://modernaesthetics.com/news/sculpsure-oked-for-back-inner-and-outer-thighs/2472220/The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure's SculpSure to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of the abdom